MORTON GROVE, Ill., July 3, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of Kefir and fermented...
WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective July 1, 2025, the company granted non-qualified stock options to purchase 10,700 shares of its common stock to two new employees under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan.
Seasoned executive brings high-growth, enterprise experience at scale to fuel customer-focused, international expansion
LOS ANGELES, July 1, 2025 /PRNewswire/ -- AuditBoard, the leading AI-powered...
Exclusive distribution of the Sebastiani Next Episode portfolio brings storied legacy brands—including Flybird, Leese-Fitch, and Smoking Loon—into a new chapter
MIAMI, July 1, 2025 /PRNewswire/...
Danville, California-based team brings $1.1 billion in assets to Steward Partners
NEW YORK, July 1, 2025 /PRNewswire/ -- Steward Partners, a full-service, employee-owned, independent financial...
AUSTIN, Texas, July 1, 2025 /PRNewswire/ -- Exfresso, the pricing and logistics automation platform for modern freight forwarders, is now publicly available for licensing...
Made with real ingredients, innovative flavors, original formulation, & fried in premium avocado oil are now available nationwide
MUSKEGO, Wis., July 1, 2025 /PRNewswire/...
Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1
Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1
TAIPEI and SHANGHAI and SAN FRANCISCO, July 1, 2025 /PRNewswire/ -- HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology...